- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04884061
Narrow Band Imaging Bronchoscopy During SARS-CoV2 Infection (SARS-CoV2-NBI)
February 9, 2023 updated by: Centre Hospitalier Universitaire, Amiens
Description of the Vasculature Pattern of the Bronchial Tree During Infection With SARS-CoV2 by Narrow Band Imaging Bronchoscopy
Vascular modifications have been described during SARS-CoV2 infection, especially a dilatation of the bronchial arteries.
Within the airway wall, small branches of the bronchial arteries cross the muscle layer to develop a submucosal network.
The Narrow Band Imaging technique is used during bronchoscopy to achieve a maximum contrast of vessels and the surrounding mucosa.
Therefore, it enables to observe the microvessel structure and its distribution in the bronchial mucosa.
The aim of this study is to describe the vasculature pattern of the bronchial tree during infection with SARS-CoV2.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
27
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Amiens, France, 80480
- CHU Amiens
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
- Patients who undergo bronchoscopy with image and/or videos recording of NBI aspect of the proximal bronchial tree (carina, right and left upper lobe).
Three groups of patients will be selected: 1) Patients hospitalized with SARS-CoV2 infection proven by RT-PCR test ; 2) patients hospitalized with lower respiratory tract infections unrelated to SARS-CoV2 (RT-PCR negative for SARS-CoV2) ; 3) Patients who have had bronchoscopy performed as part of the assessment of a distal pulmonary nodule (RT-PCR negative for SARS-CoV2).
Description
Inclusion Criteria:
- Patients who undergo bronchoscopy with image and/or videos recording of NBI aspect of the proximal bronchial tree (carina, right and left upper lobe).
- Patients hospitalized with SARS-CoV2 infection proven by RT-PCR test
- patients hospitalized with lower respiratory tract infections unrelated to SARS-CoV2 (RT-PCR negative for SARS-CoV2)
- Patients who have had bronchoscopy performed as part of the assessment of a distal pulmonary nodule (RT-PCR negative for SARS-CoV2).
Exclusion Criteria:
- Patients under legal protection
- Patients who refuses the use of his personal medical data
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Experimental
Patients hospitalized with SARS-CoV2 infection proven by RT-PCR test
|
A library of NBI images and/or videos will be established from previously recorded bronchoscopies in 30 patients (10 with a SARS-CoV2 infection, 10 with a lower respiratory tract infection not related to SARS-CoV2, and 10 in patients with pulmonary nodule).
NBI images and/or videos of the bronchial tree will then be analysed by three experimented interventional pulmonologists blinded to the patient ID.
Each investigator will describe the vasculature pattern according to a prespecified grid: Normal mucosal vascularity / increased capillary density / presence of capillary loops / presence of dotted vessels / complex vascular networks of tortuous vessels or abrupt ending vessels / dilated longitudinal vessels.
In case of discordance between the investigators, images will be reviewed to obtain a consensus.
|
|
Comparator
Patients hospitalized with lower respiratory tract infections unrelated to SARS-CoV2 (RT-PCR negative for SARS-CoV2)
|
A library of NBI images and/or videos will be established from previously recorded bronchoscopies in 30 patients (10 with a SARS-CoV2 infection, 10 with a lower respiratory tract infection not related to SARS-CoV2, and 10 in patients with pulmonary nodule).
NBI images and/or videos of the bronchial tree will then be analysed by three experimented interventional pulmonologists blinded to the patient ID.
Each investigator will describe the vasculature pattern according to a prespecified grid: Normal mucosal vascularity / increased capillary density / presence of capillary loops / presence of dotted vessels / complex vascular networks of tortuous vessels or abrupt ending vessels / dilated longitudinal vessels.
In case of discordance between the investigators, images will be reviewed to obtain a consensus.
|
|
Comparator 2
Patients who have had bronchoscopy performed as part of the assessment of a distal pulmonary nodule (RT-PCR negative for SARS-CoV2).
|
A library of NBI images and/or videos will be established from previously recorded bronchoscopies in 30 patients (10 with a SARS-CoV2 infection, 10 with a lower respiratory tract infection not related to SARS-CoV2, and 10 in patients with pulmonary nodule).
NBI images and/or videos of the bronchial tree will then be analysed by three experimented interventional pulmonologists blinded to the patient ID.
Each investigator will describe the vasculature pattern according to a prespecified grid: Normal mucosal vascularity / increased capillary density / presence of capillary loops / presence of dotted vessels / complex vascular networks of tortuous vessels or abrupt ending vessels / dilated longitudinal vessels.
In case of discordance between the investigators, images will be reviewed to obtain a consensus.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Variation of the vasculature pattern of the bronchial mucosa between the three patient groups
Time Frame: 2 months
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 7, 2021
Primary Completion (ANTICIPATED)
July 1, 2023
Study Completion (ANTICIPATED)
July 1, 2023
Study Registration Dates
First Submitted
May 7, 2021
First Submitted That Met QC Criteria
May 11, 2021
First Posted (ACTUAL)
May 12, 2021
Study Record Updates
Last Update Posted (ACTUAL)
February 10, 2023
Last Update Submitted That Met QC Criteria
February 9, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI2021_843_0096
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
-
Erasmus Medical CenterUniversity Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruiting
Clinical Trials on NBI images and/or videos
-
Nanfang Hospital, Southern Medical UniversityPrince of Wales Hospital, Shatin, Hong Kong; Wuxi People's Hospital; ZhuHai Hospital and other collaboratorsNot yet recruitingColorectal Ulcers | Computer-aided System
-
Tufts UniversityMassachusetts General Hospital; Boston Children's Hospital; Wake Forest University... and other collaboratorsActive, not recruiting
-
Portuguese Oncology Institute, CoimbraCompletedColorectal Cancer | Recurrence, Local NeoplasmPortugal
-
Nanfang Hospital, Southern Medical UniversityPrince of Wales Hospital, Shatin, Hong Kong; Wuxi People's Hospital; ZhuHai Hospital and other collaboratorsRecruitingColorectal Ulcers | Computer-aided SystemChina
-
Centre Hospitalier Charles Perrens, BordeauxRecruitingSuicidal IdeationFrance
-
Jena University HospitalCompletedNarrow Band ImagingGermany
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingVessels of the Eye FundusFrance
-
Selcuk UniversityCompletedAnxiety | Preterm Birth | Virtual Reality | Psychological Stress | Prenatal Attachment | PleasureTurkey
-
Portsmouth Hospitals NHS TrustRecruitingGastrointestinal NeoplasmsUnited Kingdom
-
Loma Linda UniversityWithdrawnStroke | Cognitive Impairment | Cognitive Change | Executive Dysfunction | Cognitive DeficitUnited States